VERU INC. Inventory, Work in Process, Gross
VERU INC. (VERU) had Inventory, Work in Process, Gross of $79.18 thousand as of 2024-09-30, per its 10-K filed 2024-12-16.
Financial Statements › Balance Sheet › Assets › Assets, Current › Inventory, Net
us-gaap:InventoryWorkInProcess · last filed 2024-12-16
- 2024-09-30: Inventory, Work in Process, Gross $79.18K.
- 2024-06-30: Inventory, Work in Process, Gross $50.48K.
- 2024-03-31: Inventory, Work in Process, Gross $49.99K.
- 2023-12-31: Inventory, Work in Process, Gross $38.25K.
| Period end | Inventory, Work in Process, Gross |
|---|---|
| 2024-09-30 | $79.18K 10-K · filed 2024-12-16 |
| 2024-06-30 | $50.48K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $49.99K 10-Q · filed 2024-05-08 |
| 2023-12-31 | $38.25K 10-Q · filed 2024-04-01 |
| 2023-09-30 | $112.80K 10-K · filed 2024-12-16 |
| 2023-06-30 | $75.85K 10-Q/A · filed 2023-11-15 |
| 2023-03-31 | $715.48K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $766.54K 10-Q · filed 2023-02-09 |
| 2022-09-30 | $872.60K 10-K/A · filed 2024-04-01 |
| 2021-09-30 | $112.92K 10-K · filed 2022-12-05 |
| 2017-09-30 | $90.16K 10-K · filed 2018-01-02 |
| 2016-06-30 | $60.12K 10-Q · filed 2016-07-28 |
| 2016-03-31 | $80.77K 10-Q · filed 2016-04-28 |
| 2015-12-31 | $69.10K 10-Q · filed 2016-02-02 |
| 2015-09-30 | $77.48K 10-K · filed 2016-12-12 |
| 2015-06-30 | $54.52K 10-Q · filed 2015-07-30 |
| 2015-03-31 | $85.49K 10-Q · filed 2015-04-30 |
| 2014-12-31 | $99.89K 10-Q · filed 2015-02-03 |
| 2014-09-30 | $15.96K 10-K · filed 2015-12-02 |
| 2014-06-30 | $49.05K 10-Q · filed 2014-07-31 |
| 2014-03-31 | $27.89K 10-Q · filed 2014-05-01 |
| 2013-12-31 | $85.61K 10-Q · filed 2014-02-03 |
| 2013-09-30 | $77.78K 10-K · filed 2014-12-02 |
| 2013-06-30 | $85.73K 10-Q · filed 2013-08-01 |
| 2013-03-31 | $92.07K 10-Q · filed 2013-05-02 |
| 2012-12-31 | $93.59K 10-Q · filed 2013-01-30 |
| 2012-09-30 | $57.10K 10-K · filed 2013-12-03 |
| 2012-06-30 | $15.71K 10-Q · filed 2012-07-31 |
| 2011-09-30 | $64.15K 10-K · filed 2012-12-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |